Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithm.
Cancer. 2023 Sep 15;129(18):2773-2788. doi: 10.1002/cncr.34904. Epub 2023 Jun 22.
Cancer. 2023.
PMID: 37349954
Review.
Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma.
Alqahtani T, Kumarasamy VM, Huczyński A, Sun D.
Alqahtani T, et al. Among authors: kumarasamy vm.
Int J Oncol. 2020 Jan;56(1):348-358. doi: 10.3892/ijo.2019.4916. Epub 2019 Nov 20.
Int J Oncol. 2020.
PMID: 31746350
Item in Clipboard
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.
Kumarasamy VM, Sun D.
Kumarasamy VM, et al.
Int J Oncol. 2017 Jul;51(1):145-157. doi: 10.3892/ijo.2017.3994. Epub 2017 May 11.
Int J Oncol. 2017.
PMID: 28498409
Free PMC article.
Item in Clipboard
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine.
Kumarasamy VM, Shin YJ, White J, Sun D.
Kumarasamy VM, et al.
BMC Cancer. 2015 Aug 26;15:599. doi: 10.1186/s12885-015-1610-5.
BMC Cancer. 2015.
PMID: 26307103
Free PMC article.
Item in Clipboard
Cite
Cite